Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Choline Acetyltransferase ELISA Kit (AC2880)
Cat.#: ASET-1469
Specifications
Description Mouse Choline Acetyltransferase ELISA Kit allows for the in vitro quantitative determination of mouse Choline Acetyltransferase concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.469 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.781-50 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2237 Human ATG3 ELISA Kit (AC3648) Quantitative inquiry ASET-1484 Mouse alpha Synuclein ELISA Kit (AC2895) Quantitative inquiry ASET-1282 Human NGF ELISA Kit (AC2693) Quantitative inquiry ASET-2489 Rat EAAT1 ELISA Kit (AC3900) Quantitative inquiry ASET-2041 Rabbit BDNF ELISA Kit (AC3452) Quantitative inquiry ASET-2404 Porcine TSH ELISA Kit (AC3815) Quantitative inquiry ASET-2391 Human CRF ELISA Kit (AC3802) Quantitative inquiry ASET-1199 Rat Neuropeptide Y ELISA Kit (AC2610) Quantitative inquiry ASET-1976 Human VAT1 ELISA Kit (AC3387) Quantitative inquiry ASET-2065 Human FLJ39155 ELISA Kit (AC3476) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket